Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With …,

Clinical trial data have shown that SM-88 has demonstrated encouraging tumor responses across 15 different cancers, including pancreatic, lung, breast …, Clinical trial data have shown that SM-88 has demonstrated encouraging tumor responses across 15 different cancers, including pancreatic, lung, breast …, Read More

Scroll to Top